Poor Prognosis With Cachexia After First-Line Immunotherapy for ES-SCLC
To analyze the link between cachexia and prognosis among patients with extensive-stage small-cell...
Read MoreMay 30, 2022
To analyze the link between cachexia and prognosis among patients with extensive-stage small-cell...
Read MoreMay 30, 2022
For a study, researchers sought to see if patients with chronic lymphocytic leukemia (CLL) who were treated at Commission on Cancer accredited academic centers (ACs), which had a high clinical volume, access to clinical trials,...
Read MoreMay 30, 2022
For a study, researchers sought to look at how patient characteristics and treatment patterns for...
Read MoreMay 30, 2022
Leukemia was the seventh most prevalent cause of mortality among cancer patients. It was...
Read MoreMay 30, 2022
During their hospitalization for rigorous chemotherapy, patients with Acute Myeloid Leukemia (AML)...
Read MoreMay 27, 2022
While the cause of multiple sclerosis (MS) was unknown, evidence showed that herpesviruses (HVs),...
Read MoreMay 27, 2022
Health professionals have urged studies to measure people’s “happiness” by...
Read MoreMay 27, 2022
Even though spasticity is prevalent, persons with multiple sclerosis (MS) with spasticity (PwMSS)...
Read MoreMay 27, 2022
Women of reproductive age were more likely to be diagnosed with multiple sclerosis (MS). Although...
Read MoreMay 23, 2022
In women with multiple sclerosis (MS) and clinically isolated syndrome (CIS), continuing disease...
Read MoreMay 23, 2022
In patients in the earlier stages of MS, an accelerated rate of spinal cord atrophy can indicate...
Read MoreMay 20, 2022
“It has previously been thought that [multiple sclerosis (MS)] is less common among non-European...
Read MoreMay 20, 2022
“Identifying an accurate prognostic biomarker in individuals with multiple sclerosis (MS) is...
Read MoreMay 19, 2022
Elevated levels of neurofilament light chain (NfL) are a known biomarker for neurodegeneration in conditions such as stroke, dementia, Multiple sclerosis, and Amyotrophic lateral sclerosis. A new study reveals that NfL may also...
Read MoreMay 19, 2022
Patients with relapsing multiple sclerosis (RMS) achieved No Evidence of Disease Activity (NEDA)...
Read MoreApr 26, 2022
Preoperative PET scanning among patients with high-risk, clinical stage 1 endometrial cancer (EC)...
Read MoreApr 25, 2022
Immunotherapy is underutilized in patients with advanced endometrial cancer (EC), even though...
Read MoreApr 25, 2022
The COVID-19 pandemic had a major effect on access to gynecologic care for women of all races and...
Read MoreApr 25, 2022
Prior research has examined sentinel lymph node (SLN) mapping among patients with a range of BMI...
Read MoreMar 31, 2022
April 2, 7:00 PM – 10:00 PM Industry Therapeutic Update from EMD Serono, Inc.: Early DMT switch considerations in MS and discussing the capacity to mount an immune response April 3, 5:00 PM – 5:30 PM AAN Leadership...
Read More